ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.645,28
0,25%
Dow Jones
40.797,95
1,46%
Euro vs US Dollar
1,08839
-0,14%
Bitcoin
64.473,73
-0,58%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) News

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DatumZeitQuelleÜberschriftSymbolFirma
01/10/201321h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
26/09/201323h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
24/09/201319h51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
24/09/201317h36Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPRXOptimizeRx Corporation
21/09/201300h01PR Newswire (US)OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. StastneyNASDAQ:OPRXOptimizeRx Corporation
21/09/201300h01PR Newswire (US)OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. StastneyNASDAQ:OPRXOptimizeRx Corporation
20/09/201323h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
13/09/201317h12PR Newswire (US)OPTIMIZERx Corporation Announces the Launch of OPTIMIZEHR® to Assist Pharmaceutical Clients with their EHR Strategies & Impl...NASDAQ:OPRXOptimizeRx Corporation
13/09/201317h12PR Newswire (US)OPTIMIZERx Corporation Announces the Launch of OPTIMIZEHR® to Assist Pharmaceutical Clients with their EHR Strategies & Impl...NASDAQ:OPRXOptimizeRx Corporation
15/08/201318h29Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
15/08/201318h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
12/08/201319h58MarketwiredOPTIMIZERx Corporation Q-2 Earnings CallNASDAQ:OPRXOptimizeRx Corporation
30/07/201314h00MarketwiredOPTIMIZERx Corporation Announces Partnership With HealthTronics to Deliver Patient Savings and SupportNASDAQ:OPRXOptimizeRx Corporation
18/07/201317h53MarketwiredOPTIMIZERx Announces Record Preliminary 2013 Second Quarter Results and UpdateNASDAQ:OPRXOptimizeRx Corporation
19/06/201319h42Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPRXOptimizeRx Corporation
17/06/201323h23Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)NASDAQ:OPRXOptimizeRx Corporation
30/05/201320h27Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)NASDAQ:OPRXOptimizeRx Corporation
30/05/201320h26Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPRXOptimizeRx Corporation
30/05/201320h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
29/05/201320h15PR Newswire (US)PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR WorkflowNASDAQ:OPRXOptimizeRx Corporation
24/05/201318h46Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:OPRXOptimizeRx Corporation
24/05/201318h46Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:OPRXOptimizeRx Corporation
24/05/201318h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
17/05/201320h49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
15/05/201317h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPRXOptimizeRx Corporation
14/05/201317h56MarketwiredOPTIMIZERx Corporation Q-1 Earnings CallNASDAQ:OPRXOptimizeRx Corporation
16/04/201316h44MarketwiredOPTIMIZERx Corporation Announces SampleMD(TM) Q1 2013 Operational UpdateNASDAQ:OPRXOptimizeRx Corporation
08/04/201322h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
15/03/201319h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
12/03/201322h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Kürzlich von Ihnen besucht

BIT
UC7V2R
Unicredit Bank
LSE
TET
Treatt
LSE
DTLE
$ Tybd 20 �hg D
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten